Wang et al. reported that fibroblasts play an important role in lung cancer resistance to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors via hepatocyte growth factor (HGF) (131). The gene discussed is HGF; the disease is lung cancer.